Wave Life Sciences Ownership | Who Owns Wave Life Sciences?
Wave Life Sciences Ownership Summary
Wave Life Sciences is owned by 49.68% institutional investors, 13.74% insiders, and 36.58% retail investors. Ra capital management is the largest institutional shareholder, holding 11.10% of WVE shares. BB Biotech AG Ord is the top mutual fund, with 2.18% of its assets in Wave Life Sciences shares.
WVE Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Wave Life Sciences | 49.68% | 13.74% | 36.58% |
| Sector | Healthcare Stocks | 232.64% | 10.66% | -143.30% |
| Industry | Biotech Stocks | 382.13% | 10.41% | -292.54% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ra capital management | 18.20M | 11.10% | $133.24M |
| Gsk | 18.25M | 10.88% | $310.18M |
| Adage capital partners gp | 14.57M | 8.88% | $106.64M |
| Blackrock funding, inc. /de | 12.65M | 7.54% | $215.03M |
| Blackrock | 6.74M | 5.21% | $33.63M |
| Maverick capital | 8.39M | 5.12% | $61.43M |
| Driehaus capital management | 6.30M | 3.84% | $46.10M |
| Artal group | 4.57M | 3.53% | $22.79M |
| M28 capital management lp | 5.66M | 3.38% | $96.30M |
| Fmr | 5.13M | 3.13% | $37.55M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| M28 capital management lp | 5.66M | 70.00% | $96.30M |
| Gsk | 18.25M | 38.82% | $310.18M |
| Pfizer | 1.88M | 13.48% | $31.88M |
| Stempoint capital lp | 2.11M | 3.09% | $15.45M |
| Kynam capital management, lp | 4.56M | 2.49% | $33.38M |
| Bioimpact capital | 1.51M | 1.80% | $11.02M |
| Ra capital management | 18.20M | 1.64% | $133.24M |
| 683 capital management | 4.15M | 1.59% | $30.38M |
| Affinity asset advisors | 2.10M | 1.34% | $15.37M |
| Emerald advisers | 2.46M | 1.29% | $41.74M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Gsk | 18.25M | 38.82% | 18.25M |
| Fmr | 5.13M | 0.00% | 4.51M |
| Blackrock funding, inc. /de | 12.65M | 0.00% | 2.22M |
| Primecap management co/ca/ | 4.10M | 0.05% | 2.20M |
| Stempoint capital lp | 2.11M | 3.09% | 1.21M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Takeda pharmaceutical | - | - | -1.35M |
| Price t rowe associates inc /md/ | 4.04M | 0.00% | -1.15M |
| Silverarc capital management | - | - | -1.05M |
| Artisan partners limited partnership | 1.23M | 0.01% | -1.03M |
| Loomis sayles & co l p | 2.04M | 0.04% | -865.24K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Gsk | 18.25M | 38.82% | 18.25M | $310.18M |
| Point72 asset management | 663.97K | 0.01% | 663.97K | $4.86M |
| Hrt financial lp | 299.72K | 0.02% | 299.72K | $5.09M |
| Eam investors | 248.81K | 0.47% | 248.81K | $4.23M |
| Renaissance | 236.42K | 0.01% | 236.42K | $4.02M |
Sold Out
| Holder | Change |
|---|---|
| National bank of canada /fi/ | -1.00 |
| Twin peaks wealth advisors | -4.00 |
| Nelson, van denburg & campbell wealth management group | -12.00 |
| Capital performance advisors llp | -13.00 |
| Corecap advisors | -24.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 141 | -31.88% | 83,339,412 | -42.00% | 49 | 0.65% | 84 | -12.50% | 32 | -49.21% |
| Sep 30, 2025 | 205 | 17.14% | 143,685,835 | 5.73% | 87 | 1.28% | 96 | -7.69% | 61 | 56.41% |
| Jun 30, 2025 | 181 | -11.27% | 138,844,683 | 5.73% | 84 | 1.30% | 106 | -9.40% | 41 | -21.15% |
| Mar 31, 2025 | 202 | 6.88% | 131,254,882 | 2.11% | 80 | 0.84% | 116 | -3.33% | 51 | 34.21% |
| Dec 31, 2024 | 81 | -50.61% | 32,943,703 | -72.58% | 25 | 0.31% | 57 | -40.00% | 14 | -64.10% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| BB Biotech AG Ord | 4.09M | 2.18% | - |
| PRIMECAP Odyssey Aggressive Growth | 3.55M | 1.89% | 1.72M |
| Federated Hermes Kaufmann R | 2.81M | 1.50% | 592.83K |
| Federated Hermes Kaufmann Growth | 2.81M | 1.50% | 592.83K |
| iShares Russell 2000 ETF | 2.80M | 1.49% | 2.80M |
| Fidelity Select Health Care | 2.80M | 1.49% | -150.00K |
| T. Rowe Price New Horizons | 2.29M | 1.22% | 468.24K |
| US Small-Cap Growth II Equity Comp | 2.29M | 1.22% | 838.97K |
| Federated Hermes Kaufmann Small Cap A | 1.87M | 1.00% | 401.57K |
| Federated Hermes Kaufmann Small Cap Grow | 1.87M | 1.00% | 401.57K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 26, 2026 | Francis Chris | See Remarks | Sell | $229.41K |
| Feb 26, 2026 | Francis Chris | See Remarks | Sell | $270.18K |
| Feb 09, 2026 | Moran Kyle | Chief Financial Officer | Sell | $48.26K |
| Feb 09, 2026 | BOLNO PAUL | President and CEO | Sell | $140.96K |
| Feb 09, 2026 | Francis Chris | See Remarks | Sell | $25.33K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | 8 |
| 2025 Q4 | 2 | 27 |
| 2025 Q3 | - | 6 |
| 2025 Q2 | - | 1 |
| 2025 Q1 | - | 2 |
WVE Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools